ShunJiang Yu

618 total citations
18 papers, 492 citations indexed

About

ShunJiang Yu is a scholar working on Molecular Biology, Neurology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, ShunJiang Yu has authored 18 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Neurology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in ShunJiang Yu's work include Fibroblast Growth Factor Research (7 papers), Neuroblastoma Research and Treatments (7 papers) and Neonatal Respiratory Health Research (5 papers). ShunJiang Yu is often cited by papers focused on Fibroblast Growth Factor Research (7 papers), Neuroblastoma Research and Treatments (7 papers) and Neonatal Respiratory Health Research (5 papers). ShunJiang Yu collaborates with scholars based in Canada and United States. ShunJiang Yu's co-authors include Shereen Ezzat, L. Sylvia, Claude Asselin, François Boudreau, Philippe Poussier, Lei Zheng, Ronald J. Weigel, Richard E. Lloyd, Antoine Désilets and Michael Bovée and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

ShunJiang Yu

18 papers receiving 489 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
ShunJiang Yu Canada 15 270 106 97 57 54 18 492
Joaquín Villar United States 12 221 0.8× 74 0.7× 78 0.8× 40 0.7× 54 1.0× 22 515
Homayoun Sadeghi United States 10 150 0.6× 145 1.4× 47 0.5× 52 0.9× 17 0.3× 19 444
Helka Parviainen Finland 14 269 1.0× 116 1.1× 248 2.6× 198 3.5× 25 0.5× 21 577
Donald E. Fleenor United States 14 248 0.9× 106 1.0× 77 0.8× 93 1.6× 47 0.9× 20 503
Maristella Steri Italy 11 216 0.8× 75 0.7× 114 1.2× 29 0.5× 28 0.5× 24 516
Berta Victoria United States 18 426 1.6× 85 0.8× 47 0.5× 32 0.6× 18 0.3× 31 747
Catherine Fortier France 14 222 0.8× 61 0.6× 78 0.8× 76 1.3× 26 0.5× 23 623
Stanley E. Hansen Japan 5 256 0.9× 147 1.4× 309 3.2× 189 3.3× 23 0.4× 7 772
Claire Vandiedonck France 16 240 0.9× 117 1.1× 217 2.2× 37 0.6× 17 0.3× 22 780
Matthew A. Powers United States 11 247 0.9× 73 0.7× 240 2.5× 163 2.9× 11 0.2× 21 615

Countries citing papers authored by ShunJiang Yu

Since Specialization
Citations

This map shows the geographic impact of ShunJiang Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by ShunJiang Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites ShunJiang Yu more than expected).

Fields of papers citing papers by ShunJiang Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by ShunJiang Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by ShunJiang Yu. The network helps show where ShunJiang Yu may publish in the future.

Co-authorship network of co-authors of ShunJiang Yu

This figure shows the co-authorship network connecting the top 25 collaborators of ShunJiang Yu. A scholar is included among the top collaborators of ShunJiang Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with ShunJiang Yu. ShunJiang Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Ezzat, Shereen, et al.. (2006). An essential role for the hematopoietic transcription factor Ikaros in hypothalamic–pituitary-mediated somatic growth. Proceedings of the National Academy of Sciences. 103(7). 2214–2219. 35 indexed citations
2.
Ezzat, Shereen, et al.. (2005). Ikaros integrates endocrine and immune system development. Journal of Clinical Investigation. 115(4). 1021–1029. 38 indexed citations
3.
Ezzat, Shereen, et al.. (2005). Ikaros integrates endocrine and immune system development. Journal of Clinical Investigation. 115(4). 1021–1029. 31 indexed citations
4.
Ezzat, Shereen, ShunJiang Yu, & L. Sylvia. (2004). The Zinc Finger Ikaros Transcription Factor Regulates Pituitary Growth Hormone and Prolactin Gene Expression through Distinct Effects on Chromatin Accessibility. Molecular Endocrinology. 19(4). 1004–1011. 30 indexed citations
5.
Yu, ShunJiang, et al.. (2004). Distinct transcriptional control and action of fibroblast growth factor receptor 4 in differentiating skeletal muscle cells. Laboratory Investigation. 84(12). 1571–1580. 14 indexed citations
6.
Yu, ShunJiang, L. Sylvia, Ronald J. Weigel, & Shereen Ezzat. (2003). Pituitary Tumor AP-2α Recognizes a Cryptic Promoter in Intron 4 of Fibroblast Growth Factor Receptor 4. Journal of Biological Chemistry. 278(22). 19597–19602. 35 indexed citations
7.
Ezzat, Shereen, ShunJiang Yu, & L. Sylvia. (2003). Ikaros Isoforms in Human Pituitary Tumors. American Journal Of Pathology. 163(3). 1177–1184. 64 indexed citations
8.
Yu, ShunJiang. (2002). Fibroblast Growth Factor Receptor 4 Is a Target for the Zinc-Finger Transcription Factor Ikaros in the Pituitary. Molecular Endocrinology. 16(5). 1069–1078. 9 indexed citations
9.
Yu, ShunJiang, Lei Zheng, L. Sylvia, & Shereen Ezzat. (2002). Fibroblast growth factor receptor 4 (FGFR4) mediates signaling to the prolactin but not the FGFR4 promoter. American Journal of Physiology-Endocrinology and Metabolism. 283(3). E490–E495. 8 indexed citations
10.
Yu, ShunJiang, L. Sylvia, & Shereen Ezzat. (2002). Fibroblast Growth Factor Receptor 4 Is a Target for the Zinc-Finger Transcription Factor Ikaros in the Pituitary. Molecular Endocrinology. 16(5). 1069–1078. 32 indexed citations
11.
Ezzat, Shereen, Lei Zheng, ShunJiang Yu, & L. Sylvia. (2001). A Soluble Dominant Negative Fibroblast Growth Factor Receptor 4 Isoform in Human MCF-7 Breast Cancer Cells. Biochemical and Biophysical Research Communications. 287(1). 60–65. 30 indexed citations
12.
Désilets, Antoine, et al.. (2000). Inhibition by Deacetylase Inhibitors of IL-1-Dependent Induction of Haptoglobin Involves CCAAT/Enhancer-Binding Protein Isoforms in Intestinal Epithelial Cells. Biochemical and Biophysical Research Communications. 276(2). 673–679. 27 indexed citations
13.
Boudreau, François, et al.. (1999). Negative regulation of glucocorticoid-dependent induction of c-fos by ras in intestinal epithelial cells. Molecular and Cellular Biochemistry. 195(1-2). 99–111. 10 indexed citations
14.
Yu, ShunJiang, François Boudreau, Antoine Désilets, et al.. (1999). Attenuation of Haptoglobin Gene Expression by TGFβ Requires the MAP Kinase Pathway. Biochemical and Biophysical Research Communications. 259(3). 544–549. 16 indexed citations
15.
Boudreau, François, ShunJiang Yu, & Claude Asselin. (1998). CCAAT/Enhancer Binding Proteins Beta and Delta Regulate α 1 -Acid Glycoprotein Gene Expression in Rat Intestinal Epithelial Cells. DNA and Cell Biology. 17(8). 669–677. 23 indexed citations
16.
Pelletier, Nadine, et al.. (1998). Activation of haptoglobin gene expression by cAMP involves CCAAT/enhancer‐binding protein isoforms in intestinal epithelial cells. FEBS Letters. 439(3). 275–280. 28 indexed citations
17.
Yu, ShunJiang, et al.. (1995). Defective RNA replication by poliovirus mutants deficient in 2A protease cleavage activity. Journal of Virology. 69(1). 247–252. 40 indexed citations
18.
Alvey, Justin, Elizabeth E. Wyckoff, ShunJiang Yu, Richard E. Lloyd, & Ellie Ehrenfeld. (1991). cis- and trans-cleavage activities of poliovirus 2A protease expressed in Escherichia coli. Journal of Virology. 65(11). 6077–6083. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joaquín Villar Breakdown of academic impact, for papers by Homayoun Sadeghi Breakdown of academic impact, for papers by Helka Parviainen Breakdown of academic impact, for papers by Donald E. Fleenor Breakdown of academic impact, for papers by Maristella Steri Breakdown of academic impact, for papers by Berta Victoria Breakdown of academic impact, for papers by Catherine Fortier Breakdown of academic impact, for papers by Stanley E. Hansen Breakdown of academic impact, for papers by Claire Vandiedonck Breakdown of academic impact, for papers by Matthew A. Powers
Rankless by CCL
2026